CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its clinical studies in the United States and Argentina,...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ: "ACXP"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat...

Full-service initiative marks a significant leap forward in getting brands to market quickly and efficiently MIAMI, Jan. 23, 2024 /PRNewswire/ -- COSMOPROF and COSMOPACK NORTH AMERICA -- Cohere...

In collaboration with leading cancer centers, research results to be presented from eight studies across four tumor types, demonstrating Caris' impact on precision medicine IRVING, Texas, Jan. 23,...

OCI Generative AI service now generally available with choice of models from Cohere and Meta in the cloud and on-premises Oracle previews the first of a series of OCI Generative AI Agents to...